LEADER 03346nam  22005773u 450 
001 996339119403316
005 20230721033021.0
010   $a1-281-96451-4
010   $a9786611964511
010   $a1-84692-584-3
035   $a(CKB)1000000000549281
035   $a(EBL)380385
035   $a(OCoLC)476208520
035   $a(SSID)ssj0000829668
035   $a(PQKBManifestationID)11443328
035   $a(PQKBTitleCode)TC0000829668
035   $a(PQKBWorkID)10798034
035   $a(PQKB)11412127
035   $a(MiAaPQ)54759
035   $a(EXLCZ)991000000000549281
100   $a20130418d2007||||  u||            |
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 10$aLymphoid Malignancies$b[electronic resource] $eAn Atlas of Investigation and Management
210   $aOxford $cAtlas Medical Publishing Ltd$d2007
215   $a1 online resource (152 p.)
300   $aDescription based upon print version of record.
311   $a1-904392-67-9 
327   $aContents; Acknowledgements; Abbreviations; Chapter 1: The molecular basisof lymphoma; Chapter 2: Acute lymphoblasticleukaemia; Chapter 3: Chronic lymphocyticleukaemia/smalllymphocytic lymphoma; Chapter 4: Prolymphocyticleukaemia; Chapter 5: Follicular lymphoma; Chapter 6: Mantle cell lymphoma; Chapter 7: Lymphoplasmacyticlymphoma; Chapter 8: Nodal marginal zonelymphoma; Chapter 9: Extranodal marginal zonelymphoma of MALT type; Chapter 10: Splenic marginal zonelymphoma, includingsplenic lymphoma withvillous lymphocytes; Chapter 11: Hairy cell leukaemia; Chapter 12: Hairy cell leukaemiavariant
327   $aChapter 13: Burkitt's lymphomaChapter 14: Diffuse large B-celllymphoma; Chapter 15: AIDS-related and otherimmunodeficiency-relatedlymphomas; Chapter 16: Adult T-cellleukaemia/lymphoma; Chapter 17: Mycosis fungoides andSe?zary syndrome; Chapter 18: Large granularlymphocyte leukaemia; Chapter 19: Aggressive NK-cellleukaemia; Chapter 20: T-cell prolymphocyticleukaemia; Chapter 21: Multiple myeloma; Chapter 22: Monoclonal gammopathyof undeterminedsignificance (MGUS); Chapter 23: Other plasma cellneoplasms; Chapter 24: Hodgkin's disease; Index
330   $aMeeting the needs for haematologists and clinical chemists for an up to date reference, this atlas provides a visual presentation of lymphoproliferative disorders, leukaemia and plasma cell neoplasms. Compiled by leading experts in the UK, each malignancy is surveyed based on molecular and cellular changes, including histochemistry, cytochemistry and relevant radiographs. Pertinent clinical information relating to clinical presentation, differential diagnosis and prognostic indicators are concisely outlined, using numerous graphics and citing key references in the field. A companion volume in 
606   $aLeukemia -- Atlases
606   $aLymphoma -- Atlases
606   $aLymphomas -- Atlases
615  4$aLeukemia -- Atlases.
615  4$aLymphoma -- Atlases.
615  4$aLymphomas -- Atlases.
676   $a616.99442
700   $aMatutes$b E$01014176
701   $aBain$b B$01014177
701   $aWotherspoon$b A$01014178
801  0$bAU-PeEL
801  1$bAU-PeEL
801  2$bAU-PeEL
906   $aBOOK
912   $a996339119403316
996   $aLymphoid Malignancies$92362034
997   $aUNISA